Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study
Glucagon-like peptide 1 agonist drugs promoted for weight loss, similar to erectile dysfunction medications more than 2 decades ago, are becoming the new blockbuster lifestyle medications for the illegal online pharmacy market. Protecting the pharmaceutical supply chain from substandard and falsified weight loss products and raising awareness regarding online medication safety must be a public health priority for regulators and technology platforms alike.
Authors
- Orsolya Balázs
- Amir Reza Ashraf (ORCID: https://orcid.org/0000-0003-0339-5653)
- Tim K. Mackey (ORCID: https://orcid.org/0000-0002-2191-7833)
- Róbert György Vida (ORCID: https://orcid.org/0000-0003-1176-0251)
- Győző Kulcsár (ORCID: https://orcid.org/0000-0002-4098-1072)
- J. Schmidt (ORCID: https://orcid.org/0000-0002-3630-9312)
- András Fittler (ORCID: https://orcid.org/0000-0002-8243-6179)
- Bálint Márk Domián
- Jiawei Li (ORCID: https://orcid.org/0000-0001-9801-4715)
- Ibolya Csákó
Institutions
- University of California San Diego (US)
- Institute of Biochemistry (HU)
- University of Pecs (HU)
Publication Details
- Journal
- Journal of Medical Internet Research
- Published
- 2024-11-07
- DOI
- https://doi.org/10.2196/65440
- Citations
- 14
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 15.53